HomeDRUG • NASDAQ
add
Bright Minds Biosciences Inc
Previous close
$42.13
Day range
$42.21 - $44.25
Year range
$0.94 - $79.02
Market cap
414.88M CAD
Avg Volume
46.90K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.03M | 1,329.52% |
Net income | -5.24M | -2,380.51% |
Net profit margin | — | — |
Earnings per share | -0.74 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 51.39M | 730.14% |
Total assets | 52.50M | 736.23% |
Total liabilities | 667.83K | 273.87% |
Total equity | 51.83M | — |
Shares outstanding | 7.08M | — |
Price to book | 5.76 | — |
Return on assets | -13.88% | — |
Return on capital | -14.02% | — |
Cash Flow
Net change in cash
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -5.24M | -2,380.51% |
Cash from operations | -3.50M | -1,559.00% |
Cash from investing | — | — |
Cash from financing | -16.87K | 23.17% |
Net change in cash | -4.29M | -1,764.94% |
Free cash flow | -2.11M | -2,755.82% |
About
Founded
2017
Website